INS and Alzheimer disease: In mouse models, CCR was observed prior to Aβ plaque formation, suggesting that soluble Aβ oligomers (AβOs) are the key in triggering CCR, potentially mediated by insulin resistance pathways, which further implies therapeutic relevance for diabetes drugs in AD [238,239,240].